Company Focus

LAMINA’S TECHNOLOGY OFFERS A RADICALLY NEW APPROACH TO A BROAD RANGE OF REGENERATIVE APPLICATIONS, INCLUDING CARTILAGE AND BONE REPAIR

Lamina’s lead product lamina.ONE consists of a nano-reservoir membrane with a controlled release mechanism for growth hormones and seeded with stem cells, offering a hybrid therapeutic action for the repair of cartilage as well as subchondral bone for a full recovery of the articular function. It will prevent the patient from having to undergo knee surgery over time.

lamina.ONE’s implantable ready to use kit and stem cells is easy to apply using a short, mini-invasive protocol, with low risk of complications, resulting in a very short recovery time and higher success rate.

lamina.ONE membrane is adjustable to the location and severity of the defect, initiating a radically new treatment approach to cartilage regeneration, tendon degeneration in insertions, and other unsolved musculoskeletal problems associated with age.

lamina.ONE’s nanostructure platform technology can control the delivery of multiple therapeutic agents in combination with different cells to accelerate tissue regeneration for multiple applications.

lamina.ONE is currently in phase I/II clinical trials for isolated osteocartilaginous lesions in the knee.